CR9495A - Composicion en emulsion estable - Google Patents

Composicion en emulsion estable

Info

Publication number
CR9495A
CR9495A CR9495A CR9495A CR9495A CR 9495 A CR9495 A CR 9495A CR 9495 A CR9495 A CR 9495A CR 9495 A CR9495 A CR 9495A CR 9495 A CR9495 A CR 9495A
Authority
CR
Costa Rica
Prior art keywords
emulsion composition
stable emulsion
regulator
adjusted
provides
Prior art date
Application number
CR9495A
Other languages
English (en)
Inventor
Asakawa Naoki
Doen Takayuki
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308111&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9495(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR9495A publication Critical patent/CR9495A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)

Abstract

La presente invencion provee una composicion en emulsion que comprende (a) un compuesto estable en un intervalo acido, y (b) un regulador de ph, en donde el ph se ajusta de aproximadamente 3.7 a aproximadamente 5.5
CR9495A 2005-04-28 2007-11-02 Composicion en emulsion estable CR9495A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005131807 2005-04-28

Publications (1)

Publication Number Publication Date
CR9495A true CR9495A (es) 2008-02-22

Family

ID=37308111

Family Applications (2)

Application Number Title Priority Date Filing Date
CR9495A CR9495A (es) 2005-04-28 2007-11-02 Composicion en emulsion estable
CR20130666A CR20130666A (es) 2005-04-28 2013-12-17 Composición de emulsión estable (divisional expediente 9495)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CR20130666A CR20130666A (es) 2005-04-28 2013-12-17 Composición de emulsión estable (divisional expediente 9495)

Country Status (24)

Country Link
US (1) US20100016381A1 (es)
EP (2) EP1875926A4 (es)
JP (2) JP5236287B2 (es)
KR (1) KR101321633B1 (es)
CN (2) CN101212986B (es)
AR (1) AR054264A1 (es)
AU (1) AU2006241671B2 (es)
BR (1) BRPI0610029A2 (es)
CA (1) CA2605773C (es)
CR (2) CR9495A (es)
GE (1) GEP20105031B (es)
IL (1) IL186673A (es)
MA (1) MA29487B1 (es)
ME (1) MEP10209A (es)
MX (1) MX2007013407A (es)
MY (1) MY147790A (es)
NO (1) NO20075985L (es)
NZ (1) NZ563225A (es)
PE (1) PE20061437A1 (es)
RU (1) RU2428204C2 (es)
TW (1) TWI462745B (es)
UA (1) UA97346C2 (es)
WO (1) WO2006118329A1 (es)
ZA (1) ZA200710193B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2018855A1 (en) * 2006-05-15 2009-01-28 Takeda Pharmaceutical Company Limited Pharmaceutical agent
WO2008060934A2 (en) * 2006-11-14 2008-05-22 Acusphere, Inc. Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
CN101229174B (zh) * 2008-01-25 2010-12-15 广东一品红药业有限公司 一种含有盐酸依匹斯汀的抗过敏组合物
US7829513B2 (en) * 2009-03-12 2010-11-09 Greenology Products, Inc. Organic cleaning composition
NZ601635A (en) 2010-01-27 2013-06-28 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
JP2012214430A (ja) * 2011-03-31 2012-11-08 Fujifilm Corp プロスタグランジン含有脂肪乳剤
EP2692360A4 (en) * 2011-03-31 2014-10-29 Fujifilm Corp FATTY EMULSION CONTAINING PROSTAGLANDIN
JP5894752B2 (ja) * 2011-03-31 2016-03-30 富士フイルム株式会社 プロスタグランジン含有脂肪乳剤
CN104602682B (zh) 2012-05-08 2018-12-14 埃罗米克斯公司 用于治疗水通道蛋白介导的疾病的化合物
AU2014346682B2 (en) 2013-11-06 2020-03-12 Aeromics, Inc. Novel formulations
US20170246136A1 (en) * 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
US12076397B2 (en) 2016-05-10 2024-09-03 The Regents Of The University Of Michigan Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
US20230248719A1 (en) * 2020-06-08 2023-08-10 Harm Reduction Therapeutics, Inc. Sterilized formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JP2836599B2 (ja) 1996-08-09 1998-12-14 日本電気株式会社 通信制御装置
DE69923300T2 (de) * 1998-03-09 2006-01-05 Takeda Pharmaceutical Co. Ltd. Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
JP3657880B2 (ja) 1998-03-11 2005-06-08 三菱電機株式会社 放電表面処理用圧粉体電極
KR100778256B1 (ko) * 1999-08-06 2007-11-27 다케다 야쿠힌 고교 가부시키가이샤 치환 방향환 화합물, 그의 제조법 및 용도
US6532316B1 (en) * 1999-11-10 2003-03-11 Avanex Corporation Bi-directional polarization-independent optical isolator
JP4863553B2 (ja) * 2000-02-04 2012-01-25 武田薬品工業株式会社 安定な乳化組成物
CA2400804C (en) * 2000-02-04 2009-09-01 Takeda Chemical Industries, Ltd. Stable emulsion compositions of cycloalkene derivatives
JP2003033195A (ja) * 2001-07-24 2003-02-04 Kyowa Hakko Kogyo Co Ltd テトラヒドロクルクミン類の製造方法
JP5137289B2 (ja) * 2001-08-03 2013-02-06 武田薬品工業株式会社 安定な乳化組成物
US20030220284A1 (en) * 2002-02-22 2003-11-27 Patricia Yotnda Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
JPWO2004052354A1 (ja) * 2002-12-06 2006-04-06 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
ES2390055T3 (es) * 2003-10-03 2012-11-06 Ono Pharmaceutical Co., Ltd. Fármaco que contiene ácido(2R)-2-propiloctanoico como principio activo
US20090062355A1 (en) * 2006-04-20 2009-03-05 Takeda Pharmaceutical Company Limited Pharmaceutical Product

Also Published As

Publication number Publication date
NZ563225A (en) 2011-01-28
AU2006241671A1 (en) 2006-11-09
CN101212986A (zh) 2008-07-02
AR054264A1 (es) 2007-06-13
MY147790A (en) 2013-01-31
IL186673A0 (en) 2008-01-20
CR20130666A (es) 2014-03-13
TWI462745B (zh) 2014-12-01
WO2006118329A1 (ja) 2006-11-09
EP1875926A1 (en) 2008-01-09
TW200724159A (en) 2007-07-01
AU2006241671B2 (en) 2012-06-07
MEP10209A (en) 2011-12-20
US20100016381A1 (en) 2010-01-21
JPWO2006118329A1 (ja) 2008-12-18
JP5236287B2 (ja) 2013-07-17
NO20075985L (no) 2008-01-25
CN101212986B (zh) 2015-01-14
MX2007013407A (es) 2008-01-15
CA2605773A1 (en) 2006-11-09
PE20061437A1 (es) 2007-01-25
EP2255785A3 (en) 2013-01-16
GEP20105031B (en) 2010-06-25
EP1875926A4 (en) 2013-01-16
KR20080011413A (ko) 2008-02-04
UA97346C2 (ru) 2012-02-10
CA2605773C (en) 2014-04-08
RU2007144071A (ru) 2009-06-10
MA29487B1 (fr) 2008-05-02
CN102670503A (zh) 2012-09-19
EP2255785A2 (en) 2010-12-01
JP2013040215A (ja) 2013-02-28
KR101321633B1 (ko) 2013-10-22
BRPI0610029A2 (pt) 2011-10-11
ZA200710193B (en) 2009-07-29
RU2428204C2 (ru) 2011-09-10
IL186673A (en) 2013-08-29

Similar Documents

Publication Publication Date Title
CR20130666A (es) Composición de emulsión estable (divisional expediente 9495)
AR116860A2 (es) Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
UY31633A1 (es) Plaguicidas mesoiónicos
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
HN2006016313A (es) Derivados de amida sustituida y metodos de uso
CO6382079A2 (es) Composiciones insecticidas estables a base de sulfoximina
ATE417511T1 (de) Durchlüftete produkte mit niedrigem ph-wert
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
MX2007015424A (es) Formulaciones ungueales topicas.
CR9230A (es) Uso de derivados del acido tetramico para el control de los insectos del genero de los hemipteros (sternorrhyncha)
BRPI0418330A (pt) composições sólidas de drogas de solubilidade baixa e poloxámeros
CR10303A (es) "derivados de quinolina y su uso com pesticidas"
CY1112950T1 (el) Νηματωδοκτονες συνθεσεις
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
AR058271A1 (es) Compuesto herbicida a base de fenoxaprop.
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
BRPI0507915A (pt) uso de derivados de pirimidina como fungicidas agrìcolas e horticulturais
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen
BRPI0511932A (pt) métodos para controlar cupins
BRPI0514452A (pt) composições, métodos de fabricação e uso de compostos de guanilhidrazona
ATE461189T1 (de) Neue 6-pyridylphenanthridine
BRPI0517302A (pt) processo de preparação de compostos de pirimidina